Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complexation Equilibria: The Chelate Effect01:19

Complexation Equilibria: The Chelate Effect

435
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
435
Extraction: Advanced Methods00:56

Extraction: Advanced Methods

409
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
409
EDTA: Chemistry and Properties01:22

EDTA: Chemistry and Properties

1.7K
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
1.7K
Metal-Ligand Bonds02:51

Metal-Ligand Bonds

20.5K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
20.5K
Masking and Demasking Agents01:19

Masking and Demasking Agents

2.3K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
2.3K
Colors and Magnetism03:02

Colors and Magnetism

11.5K
Color in Coordination Complexes
When atoms or molecules absorb light at the proper frequency, their electrons are excited to higher-energy orbitals. For many main group atoms and molecules, the absorbed photons are in the ultraviolet range of the electromagnetic spectrum, which cannot be detected by the human eye. For coordination compounds, the energy difference between the d orbitals often allows photons in the visible range to be absorbed and emitted, which is seen as colors by the human...
11.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial Function Under Combined Oral Contraceptive Exposure in a Neuroblastoma Model: A Preliminary Investigation.

Biomedicines·2026
Same author

Gender Medicine and Pharmacology.

Biomedicines·2025
Same author

Collection Series "Iron Homeostasis".

International journal of molecular sciences·2025
Same author

Role of <i>OCT1</i> and <i>MAP3K5</i> Genetic Polymorphisms in Hydroxyurea Pharmacokinetics.

Life (Basel, Switzerland)·2025
Same author

Steroidomics via Gas Chromatography-Mass Spectrometry (GC-MS): A Comprehensive Analytical Approach for the Detection of Inborn Errors of Metabolism.

Life (Basel, Switzerland)·2025
Same author

Macrophage and cardiomyocyte roles in cardioprotection: Exploiting the NLRP3 Inflammasome inhibitor INF150.

Vascular pharmacology·2025

Related Experiment Video

Updated: Jun 3, 2025

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

406

Sex and Gender Differences in Iron Chelation.

Sarah Allegra1, Stefano Comità1, Antonella Roetto1

  • 1Department of Clinical and Biological Sciences, University of Turin, San Luigi Gonzaga University Hospital, 10043 Orbassano, Italy.

Biomedicines
|January 8, 2025
PubMed
Summary

Iron chelation therapy is crucial for managing iron overload. However, current treatments often overlook sex and gender differences, potentially affecting efficacy and safety.

Keywords:
deferasiroxdeferipronedeferoxamineiron overloadluspaterceptpersonalized medicine

More Related Videos

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

4.4K
Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
04:48

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII

Published on: May 4, 2020

8.0K

Related Experiment Videos

Last Updated: Jun 3, 2025

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

406
Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay
05:08

Measurement of Tissue Non-Heme Iron Content using a Bathophenanthroline-Based Colorimetric Assay

Published on: January 31, 2022

4.4K
Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII
04:48

Setup of Capillary Electrophoresis-Inductively Coupled Plasma Mass Spectrometry CE-ICP-MS for Quantification of Iron Redox Species FeII, FeIII

Published on: May 4, 2020

8.0K

Area of Science:

  • Pharmacology
  • Hematology
  • Endocrinology

Background:

  • Iron overload necessitates chelation therapy due to the body's inability to excrete excess iron.
  • Physiological processes influencing drug pharmacokinetics (absorption, distribution, metabolism, excretion) vary significantly between sexes and genders.
  • These variations can impact the effectiveness and safety of iron overload treatments.

Purpose of the Study:

  • To review existing literature concerning the assessment and treatment of iron overload, with a specific focus on sex and gender differences.
  • To highlight the need for personalized approaches in iron chelation therapy.

Main Methods:

  • Comprehensive literature search on iron overload, chelation therapy, and sex/gender-related factors.
  • Analysis of studies examining individual patient factors influencing treatment response and toxicity.

Main Results:

  • Iron chelators are effective in reducing iron levels and preventing organ damage.
  • Existing research often fails to differentiate between male and female patients, neglecting the impact of hormonal variations, particularly in women.
  • Individual factors influencing chelation treatment efficacy and toxicity are documented but rarely analyzed through a sex- and gender-specific lens.

Conclusions:

  • Effective iron chelation therapy must acknowledge and incorporate sex and gender differences.
  • Future research should investigate hormonal influences on iron metabolism and chelation therapy response.
  • Personalized treatment strategies considering sex and gender are essential for optimizing patient outcomes in iron overload management.